GP Phenyl 100

GP Phenyl 100 – Nandrolone Phenylpropionate Overview

GP Phenyl 100 is an injectable anabolic steroid from Geneza Pharmaceuticals containing Nandrolone Phenylpropionate at 100 mg/mlin a 10 ml vial. Nandrolone Phenylpropionate is the short-ester formulation of Nandrolone – the same 19-nor compound as Nandrolone Decanoate (Deca / GP Deca 300), but with a Phenylpropionate ester that gives a half-life of approximately 3-4 days and allows faster clearance. Originally sold under the brand name Durabolin, NPP is the most consistently used abbreviation in community discussions. Commonly searched as NPP, Nandrolone PP, Durabolin, Nandrolone Phenylpropionate 100, and Geneza NPP.

What Is Nandrolone Phenylpropionate?

Nandrolone Phenylpropionate is a 19-nor anabolic compound – the same active molecule as Nandrolone Decanoate but paired with the shorter Phenylpropionate ester. The 19-nor classification means the compound lacks the 19th carbon of the testosterone molecule, producing a compound with different pharmacological properties including progestogenic activity and low aromatization. NPP aromatizes to estrogen at approximately 20% the rate of testosterone – lower than Deca at equivalent doses, though the difference is attributed primarily to shorter blood level exposure per injection rather than a pharmacological distinction. The Phenylpropionate ester produces a half-life of approximately 3-4 days, requiring EOD or three-times-weekly injections for stable blood levels, but allowing PCT to begin approximately 7-10 days after the last injection – significantly earlier than Deca’s approximately 21-day wait.

Why Users Search for GP Phenyl 100

NPP is searched primarily as a faster-clearing alternative to Deca (Nandrolone Decanoate). NPP vs Deca is the most consistently searched Nandrolone topic in community discussions – the comparison centers on ester differences, injection frequency, side effect management flexibility, and PCT timing. NPP is referenced in both bulking and cutting contexts, whereas Deca is predominantly cited in bulking frameworks. The faster clearance makes NPP more flexible for side effect management – if prolactin or progestogenic issues arise, they resolve faster with the Phenylpropionate ester than with Decanoate. Joint support and connective tissue context is a consistently cited search angle for all Nandrolone formulations including NPP.

• Active substance: Nandrolone Phenylpropionate – 19-nor injectable, short-ester Nandrolone, faster clearance than Deca.
• Concentration: 100 mg/ml in a 10 ml vial – 1000 mg Nandrolone Phenylpropionate total content.
• Injection schedule: EOD or three-times-weekly cited for blood level stability with the Phenylpropionate ester.
• Common names: NPP, Nandrolone PP, Durabolin, Nandrolone Phenylpropionate, Phenyl Nandrolone, Geneza NPP.
• Cycle context: Test + NPP stack (bulking and body recomposition); faster-clearing Deca alternative with earlier PCT start timing.

GP Phenyl 100 Dose and Concentration Information

GP Phenyl 100 is listed at 100 mg/ml. A 10 ml vial contains 1000 mg Nandrolone Phenylpropionate in total. The Phenylpropionate ester produces a half-life of approximately 3-4 days, making EOD or three-times-weekly injections the most consistently referenced schedule for stable blood levels. This injection frequency is more demanding than Nandrolone Decanoate’s once-weekly or twice-weekly schedule, but allows faster blood level stabilization and significantly earlier PCT timing.

Concentration and Ester Context

100 mg/ml is the standard concentration for injectable Nandrolone Phenylpropionate. The Phenylpropionate ester’s half-life of approximately 3-4 days gives NPP a clearance profile significantly faster than Nandrolone Decanoate (half-life approximately 6-7 days via the Decanoate ester, with full clearance taking considerably longer). PCT can begin approximately 7-10 days after the last NPP injection, compared to approximately 21 days after the last Deca injection – the most consistently cited practical advantage of NPP over Deca in community references. Stable blood levels are reached more quickly with NPP than with Deca, making it more suitable for shorter cycle frameworks.

Bloodwork and Monitoring Context

Nandrolone Phenylpropionate’s progestogenic activity means prolactin monitoring is a referenced consideration for all NPP cycles – identical to the monitoring profile for Nandrolone Decanoate. Cabergoline is cited for prolactin management. Estrogen monitoring from the aromatizing testosterone compound used alongside NPP is standard. Lipid panel, hematocrit, and blood pressure are the general injectable cycle bloodwork references. HPTA suppression is complete with NPP – a testosterone base is universally cited as mandatory alongside all Nandrolone Phenylpropionate cycles.

• Concentration: 100 mg/ml – standard Nandrolone Phenylpropionate injectable concentration.
• Total content: 1000 mg Nandrolone Phenylpropionate per 10 ml vial.
• Injection schedule: EOD or 3x-weekly cited for blood level stability – more frequent than Deca but allows faster PCT start.
• PCT timing: Approximately 7-10 days post-last-injection – significantly earlier than Deca’s approximately 21-day wait.
• Bloodwork context: Prolactin, lipid panel, estrogen (from testosterone base), hematocrit, blood pressure – standard monitoring for NPP cycles.
• Testosterone base: Universally cited as mandatory alongside all NPP cycles – HPTA suppression is complete.